RWA WEALTH PARTNERS, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1544576 BOSTON, MA

Position in REGN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$307,405

-$105 QoQ

Shares Held

493

+23.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#942

of 1,322 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RWA WEALTH PARTNERS, LLC holds $2,823,823 across 5 Biotechnology names. REGN ranks #5 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,714	$1,348,124
2	EXEL	Exelixis, Inc.	8,806	$479,134
3	CRNX	Crinetics Pharmaceuticals, Inc.	9,271	$346,920
4	BHVN	Biohaven Ltd.	23,000	$342,240
5	REGN	Regeneron Pharmaceuticals, Inc. This page	493	$307,405

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$307,405	493	+23.9%	Shares	Sole	2026-08-07
2026-03-31	$307,510	398	-0.5%	Shares	Sole	2026-05-13
2025-12-31	$308,748	400	-93.9%	Shares	Sole	2026-02-12
2025-09-30	$3,713,230	6,604	-13.1%	Shares	Sole	2025-11-10
2025-06-30	$3,988,950	7,598	-57.7%	Shares	Sole	2025-08-06
2025-03-31	$11,397,113	17,970	-2.5%	Shares	Sole	2025-05-13
2024-12-31	$13,125,392	18,426	+4518.0%	Shares	Sole	2025-02-12
2024-09-30	$419,444	399	+0.5%	Shares	Sole	2024-11-08
2024-06-30	$417,258	397	0.0%	Shares	Sole	2024-08-12
2024-03-31	$382,108	397	-7.0%	Shares	Sole	2024-04-29
2023-12-31	$375,029	427	-57.2%	Shares	Sole	2024-02-01
2020-03-31	$487,313	998	—	Shares	Sole	2020-04-08
No filing history on record for this holder in this stock.